Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor. (8th May 2019) - Gooderham, M.; Elewski, B.E.; Pariser, D.M.; Sofen, H.; Mendelsohn, A.M.; Rozzo, S.J.; Li, Q.